JP6487635B2 - Liquid oil composition - Google Patents
Liquid oil composition Download PDFInfo
- Publication number
- JP6487635B2 JP6487635B2 JP2014113203A JP2014113203A JP6487635B2 JP 6487635 B2 JP6487635 B2 JP 6487635B2 JP 2014113203 A JP2014113203 A JP 2014113203A JP 2014113203 A JP2014113203 A JP 2014113203A JP 6487635 B2 JP6487635 B2 JP 6487635B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- preferable
- group
- oil composition
- liquid oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 72
- 239000007788 liquid Substances 0.000 title claims description 55
- 239000003921 oil Substances 0.000 claims description 74
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000004215 Carbon black (E152) Substances 0.000 claims description 7
- 239000010696 ester oil Substances 0.000 claims description 7
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 229930182558 Sterol Natural products 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 150000003432 sterols Chemical class 0.000 claims description 6
- 235000003702 sterols Nutrition 0.000 claims description 6
- 125000006165 cyclic alkyl group Chemical group 0.000 claims description 3
- 150000001983 dialkylethers Chemical class 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 description 69
- -1 neosbongosterol Natural products 0.000 description 33
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 24
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 15
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 12
- 230000002688 persistence Effects 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 8
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 7
- 125000003342 alkenyl group Chemical group 0.000 description 7
- 229960000541 cetyl alcohol Drugs 0.000 description 7
- 229940073724 cholesteryl isostearate Drugs 0.000 description 7
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 7
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 7
- 229940032094 squalane Drugs 0.000 description 7
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 6
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 5
- XMFUMMRWIFOQDQ-UHFFFAOYSA-N 1-(4-methylpentan-2-yloxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOC(C)CC(C)C XMFUMMRWIFOQDQ-UHFFFAOYSA-N 0.000 description 5
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 5
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 5
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 5
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 5
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 5
- 229940100554 isononyl isononanoate Drugs 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 4
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 2
- KZJWDPNRJALLNS-FBZNIEFRSA-N clionasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-FBZNIEFRSA-N 0.000 description 2
- QYIXCDOBOSTCEI-NWKZBHTNSA-N coprostanol Chemical compound C([C@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-NWKZBHTNSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229940093629 isopropyl isostearate Drugs 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229930193551 sterin Natural products 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000005068 transpiration Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- UPGTYLFCVNHBTN-UHFFFAOYSA-N (20Z)-cholest-5,20(22)-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CCC(C)C)C1(C)CC2 UPGTYLFCVNHBTN-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IKYKEVDKGZYRMQ-PDBXOOCHSA-N (9Z,12Z,15Z)-octadecatrien-1-ol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCO IKYKEVDKGZYRMQ-PDBXOOCHSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- JNYGZAJRVPTELQ-UHFFFAOYSA-N 2-ethylhexanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCC(CC)C(O)=O.CCCCC(CC)C(O)=O.CCCCC(CC)C(O)=O JNYGZAJRVPTELQ-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- INDVLXYUCBVVKW-RNWIMVDMSA-N 24-Methylene cholesterol Natural products O[C@@H]1CC=2[C@@](C)([C@H]3[C@H]([C@H]4[C@@](C)([C@@H]([C@@H](CCC(C(C)C)=C)C)CC4)CC3)CC=2)CC1 INDVLXYUCBVVKW-RNWIMVDMSA-N 0.000 description 1
- INDVLXYUCBVVKW-PXBBAZSNSA-N 24-methylenecholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCC(=C)C(C)C)[C@@]1(C)CC2 INDVLXYUCBVVKW-PXBBAZSNSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- ARYTXMNEANMLMU-UHFFFAOYSA-N 24alpha-methylcholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 ARYTXMNEANMLMU-UHFFFAOYSA-N 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- QOXPZVASXWSKKU-UEIWAABPSA-N 5alpha-ergosta-7,22-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 QOXPZVASXWSKKU-UEIWAABPSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical group CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- QSVJYFLQYMVBDR-UHFFFAOYSA-N Ergosterin Natural products C1C(O)CCC2(C)C3=CCC4(C)C(C(C)C=CC(C)C(C)C)CCC4C3=CC=C21 QSVJYFLQYMVBDR-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- INDVLXYUCBVVKW-UHFFFAOYSA-N Methylencholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=C)C(C)C)C1(C)CC2 INDVLXYUCBVVKW-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- ACIAHEMYLLBZOI-ZZXKWVIFSA-N Unsaturated alcohol Chemical compound CC\C(CO)=C/C ACIAHEMYLLBZOI-ZZXKWVIFSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- ARYTXMNEANMLMU-ATEDBJNTSA-N campestanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]2(C)CC1 ARYTXMNEANMLMU-ATEDBJNTSA-N 0.000 description 1
- UPGTYLFCVNHBTN-OFAYOZIESA-N cholesta-5,22E-dien-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/CC(C)C)[C@@]1(C)CC2 UPGTYLFCVNHBTN-OFAYOZIESA-N 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- QSVJYFLQYMVBDR-CMNOFMQQSA-N dehydroergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]4C3=CC=C21 QSVJYFLQYMVBDR-CMNOFMQQSA-N 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- ZKQRGSXITBHHPC-VVQHAZRASA-N ergosta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 ZKQRGSXITBHHPC-VVQHAZRASA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- PUGBZUWUTZUUCP-ZRKHGVCBSA-N fungisterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@H](C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 PUGBZUWUTZUUCP-ZRKHGVCBSA-N 0.000 description 1
- UHQOYWRQNBWEAM-NBPRQAIYSA-N fungisterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@@H]1CC[C@@H]2C3=C(CC[C@]12C)[C@@]4(C)CC[C@@H](O)C[C@H]4C=C3 UHQOYWRQNBWEAM-NBPRQAIYSA-N 0.000 description 1
- KZJWDPNRJALLNS-STIDJNKJSA-N gamma-sitosterol Natural products CC[C@@H](CC[C@@H](C)[C@@H]1CC[C@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C KZJWDPNRJALLNS-STIDJNKJSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical class C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- QOXPZVASXWSKKU-UHFFFAOYSA-N stellasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(C)C(C)C)CCC33)C)C3=CCC21 QOXPZVASXWSKKU-UHFFFAOYSA-N 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- MAYCICSNZYXLHB-UHFFFAOYSA-N tricaproin Chemical compound CCCCCC(=O)OCC(OC(=O)CCCCC)COC(=O)CCCCC MAYCICSNZYXLHB-UHFFFAOYSA-N 0.000 description 1
- 125000002469 tricosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、液状オイル組成物に関する。 The present invention relates to a liquid oil composition.
オイル製剤は肌をなめらかに保ち、保湿効果に優れることから、肌への使用以外にも、髪などに使用されたり、クレンジングとして使用されたり、幅広く利用されている。
保湿ケア剤としては、スクワランや流動パラフィンなどの炭化水素系の油性成分を含むオイル製剤が提案されている(特許文献1〜3)。これらのオイル製剤は肌表面を油分で覆い、皮膚からの水分の蒸散を制御して、皮膚を柔軟にする効果及び保湿効果を発揮するとされている。また、これらのオイル製剤では、植物由来で、安全性にも優れるホホバ油が頻繁に用いられている。
Oil preparations keep skin smooth and have excellent moisturizing effects, so that they are used not only for skin, but also for hair, cleansing, etc.
As a moisturizing care agent, an oil preparation containing hydrocarbon oily components such as squalane and liquid paraffin has been proposed (Patent Documents 1 to 3). These oil preparations are said to cover the skin surface with oil and to control the transpiration of moisture from the skin to exert the effect of softening the skin and the moisturizing effect. In these oil preparations, jojoba oil derived from plants and excellent in safety is frequently used.
一方、凍結を防止したオイル製剤も提案されている(特許文献4)。このオイル製剤では、凍結防止のための溶剤が用いられ、その使用感は軽く、オイル製剤本来の肌表面を覆う機能が低下したさっぱりとしたものである。 On the other hand, an oil formulation that prevents freezing has also been proposed (Patent Document 4). In this oil preparation, a solvent for preventing freezing is used, the feeling of use is light, and the function of covering the original skin surface of the oil preparation is reduced.
特許文献1〜3に記載されているオイル製剤等で用いられているホホバ油は、低温で凍結する性質を有するため、このようなオイル製剤においては、冬場などに、しばしば凍結が起こり、オイル製剤を融解させて使用しなければならない。
また、肌表面を覆い、水分の蒸散を抑えるためには、使用感の重い油(固体状の油性成分)が優れているが、溶剤を含有する特許文献4のオイル製剤では、低温での結晶析出などの安定性の問題や、肌なじみの点などから、その利用は困難であった。
本発明は、安定性が良好であるとともに、肌を覆う機能に優れ、なめらかさなどの使用感に優れた液状オイル組成物に関する。
Since jojoba oil used in the oil preparations and the like described in Patent Documents 1 to 3 has a property of freezing at low temperatures, such oil preparations often freeze in winter and the oil preparations. Must be melted before use.
In addition, in order to cover the skin surface and suppress the transpiration of moisture, heavy oil (solid oily component) is excellent. However, in the oil preparation of Patent Document 4 containing a solvent, crystals at a low temperature are used. Its use has been difficult due to stability problems such as precipitation and familiarity with the skin.
The present invention relates to a liquid oil composition having excellent stability, an excellent function of covering the skin, and excellent usability such as smoothness.
本発明者らは、ステロール類、特定の高級脂肪酸、エステル油及び/又はエーテル油、炭化水素油、シリコーン油、高級アルコールを特定の割合で組み合わせて用いれば、前記課題を解決した液状オイル組成物が得られることを見出した。 When the present inventors use sterols, specific higher fatty acids, ester oils and / or ether oils, hydrocarbon oils, silicone oils, and higher alcohols in a specific ratio, a liquid oil composition that solves the above-mentioned problems. It was found that can be obtained.
本発明は、次の成分(A)、(B)、(C)、(D)、(E)及び(F):
(A)ステロール類 0.01〜1質量%、
(B)20℃で液状の炭素数12〜24の高級脂肪酸 0.1〜10質量%、
(C)エステル油及び/又はエーテル油 0.5〜50質量%、
(D)炭化水素油 8〜80質量%、
(E)25℃における粘度が20mPa・s以下のシリコーン油 5〜80質量%、
(F)炭素数12〜24の高級アルコール 1〜15質量%
を含有する液状オイル組成物に関する。
The present invention includes the following components (A), (B), (C), (D), (E) and (F):
(A) Sterols 0.01-1% by mass,
(B) 0.1 to 10% by mass of a higher fatty acid having 12 to 24 carbon atoms which is liquid at 20 ° C.
(C) Ester oil and / or ether oil 0.5-50 mass%,
(D) 8 to 80% by mass of hydrocarbon oil,
(E) 5 to 80% by mass of a silicone oil having a viscosity at 25 ° C. of 20 mPa · s or less,
(F) 1 to 15% by mass of a higher alcohol having 12 to 24 carbon atoms
The present invention relates to a liquid oil composition containing
本発明の液状オイル組成物は、保存安定性、特に低温での保存安定性が良好で、肌へのなじみが良く、なめらかで、皮膚への残留性に優れ、しっとり感を与え、保湿効果の持続に優れたものである。 The liquid oil composition of the present invention has good storage stability, particularly storage stability at low temperatures, is well-familiar with the skin, is smooth, has excellent persistence on the skin, gives a moist feeling, and has a moisturizing effect. It has excellent sustainability.
(A)ステロール類:
本発明で用いられる成分(A)のステロール類としては、ステロール骨格を有する物質及びその誘導体であればいずれでも良く、例えば、コレステロール、イソステアリン酸コレステリル、プロビタミンD3、カンベステロール、ステグマスタノール、ステグマステロール、5−ジヒドロコレステロール、α−スピナステロール、パリステロール、クリオナステロール、γ−シトステロール、ステグマステノール、サルガステロール、アペナステロール、エルゴスタノール、シトステロール、コルビステロール、コンドリラステロール、ポリフェラステロール、ハリクロナステロール、ネオスボンゴステロール、フコステロール、アプトスタノール、エルゴスタジエノール、エルゴステロール、22−ジヒドロエルゴステロール、ブラシカステロール、24−メチレンコレステロール、5−ジヒドロエルゴステロール、デヒドロエルゴステロール、フンギステロール、コレスタノール、コプロスタノール、ジモステロール、7−ヘトコレステロール、ラトステロール、22−デヒドロコレステロール、β−シトステロール、コレスタトリエン−3β−オール、コプロスタノール、コレスタノール、エルゴステロール、7−デヒドロコレステロール、24−デヒドロコレスタジオン−3β−オール、エキレニン、エキリン、エストロン、17β−エストラジオール、アンドロスト−4−エン−3β,17β−ジオール、デヒドロエビアンドロステロン、アルケニルコハク酸コレステロール等が挙げられる。
アルケニルコハク酸コレステロールとしては、特開平5−294989号記載のものが好ましく、具体的には、下記一般式(1)で表されるステリン誘導体が好ましい。
(A) Sterols:
The sterols of component (A) used in the present invention may be any substance having a sterol skeleton and derivatives thereof, such as cholesterol, cholesteryl isostearate, provitamin D3, camsterol, stegmasteranol, and stegmasterol. , 5-dihydrocholesterol, α-spinasterol, parisosterol, cryonasterol, γ-sitosterol, stigmasterenol, salgasterol, apesterol, ergostanol, sitosterol, corvisterol, chondrasterol, polyferasterol, halicrona Sterol, neosbongosterol, fucosterol, aptostanol, ergostadienol, ergosterol, 22-dihydroergosterol, brush caster , 24-methylenecholesterol, 5-dihydroergosterol, dehydroergosterol, fungisterol, cholestanol, coprostanol, dimosterol, 7-hetcholesterol, latosterol, 22-dehydrocholesterol, β-sitosterol, cholestatriene -3β-ol, coprostanol, cholestanol, ergosterol, 7-dehydrocholesterol, 24-dehydrocholestanenone-3β-ol, echilenin, echrin, estrone, 17β-estradiol, androst-4-en-3β, 17β -Diol, dehydro shrimp androsterone, alkenyl succinate cholesterol and the like.
As the alkenyl succinic acid cholesterol, those described in JP-A-5-294899 are preferable, and specifically, a sterin derivative represented by the following general formula (1) is preferable.
〔式中、R1:1個の水酸基を有するコレステロール又はその水素添加物(以下、ステリン類という。)の水酸基の水素原子を除いたあとに残る残基を示す。 [Wherein R 1 represents a residue remaining after removal of a hydrogen atom of a hydroxyl group of cholesterol having one hydroxyl group or a hydrogenated product thereof (hereinafter referred to as sterins).
(R3は、炭素数6〜20の直鎖もしくは分岐鎖のアルケニル基を示す。)で表される基を示す。
M:水素原子、アルカリ金属、アルカリ土類金属、アンモニウム、総炭素数2〜9のアルカノールアンモニウム、総炭素数1〜22のアルキルアンモニウムもしくはアルケニルアンモニウム、炭素数1〜18のアルキル基もしくはアルケニル基で置換されたピリジニウム、又は塩基性アミノ酸を示す。〕
(R 3 represents a straight-chain or branched alkenyl group having 6 to 20 carbon atoms).
M: hydrogen atom, alkali metal, alkaline earth metal, ammonium, alkanol ammonium having 2 to 9 carbon atoms, alkyl ammonium or alkenyl ammonium having 1 to 22 carbon atoms, alkyl group or alkenyl group having 1 to 18 carbon atoms A substituted pyridinium or basic amino acid is shown. ]
これらのうち、液状オイル組成物の皮膚への残留性を向上させる観点から、コレステロール、イソステアリン酸コレステリル、プロビタミンD3、シトステロール、アルケニルコハク酸コレステロールが好ましく、コレステロール、イソステアリン酸コレステリル、アルケニルコハク酸コレステロールがより好ましく、アルケニルコハク酸コレステロールとしては、前記一般式(1)で表されるステリン誘導体が好ましい。 Of these, cholesterol, cholesteryl isostearate, provitamin D3, sitosterol, cholesterol alkenyl succinate are preferred from the viewpoint of improving the persistence of the liquid oil composition on the skin, and cholesterol, cholesteryl isostearate, cholesterol alkenyl succinate are preferred. More preferably, the alkenyl succinate cholesterol is preferably a sterine derivative represented by the general formula (1).
成分(A)は、1種又は2種以上を組み合わせて用いることができ、その含有量は、液状オイル組成物の皮膚への残留性を向上させる観点から、全組成中に0.01質量%以上であり、0.02質量%以上が好ましく、0.05質量%以上がより好ましく、1質量%以下であり、0.8質量%以下が好ましく、0.5質量%以下がより好ましい。また、成分(A)の含有量は、全組成中に0.01〜1質量%であり、0.02〜0.8質量%が好ましく、0.05〜0.5質量%がより好ましい。 Component (A) can be used alone or in combination of two or more thereof, and its content is 0.01% by mass in the total composition from the viewpoint of improving the persistence of the liquid oil composition on the skin. It is above, 0.02 mass% or more is preferable, 0.05 mass% or more is more preferable, 1 mass% or less is preferable, 0.8 mass% or less is preferable, and 0.5 mass% or less is more preferable. Moreover, content of a component (A) is 0.01-1 mass% in the whole composition, 0.02-0.8 mass% is preferable, and 0.05-0.5 mass% is more preferable.
(B)20℃で液状の炭素数12〜24の高級脂肪酸:
本発明で用いられる成分(B)は、20℃で液状の炭素数12〜24の高級脂肪酸であり、直鎖状又は分岐鎖状の飽和又は不飽和の炭化水素基を有するものである。本発明において、20℃で液状とは、ASTM規格 ASTMD4359−90に規定される固液判定基準により、液状と判断されるものである。
成分(B)の高級脂肪酸としては、炭素数12〜24の不飽和脂肪酸、分岐脂肪酸が挙げられ、例えば、オレイン酸、パルミトレイン酸、リノール酸、リノレン酸、イソステアリン酸、イソパルミチン酸等が挙げられる。また、大豆油、綿実油等の植物油又は硬化油から抽出した分岐脂肪酸や、植物油を原料とするダイマー酸の製造における副産物として生成する分岐脂肪酸などを使用することもできる。
(B) A higher fatty acid having 12 to 24 carbon atoms which is liquid at 20 ° C .:
The component (B) used in the present invention is a higher fatty acid having 12 to 24 carbon atoms that is liquid at 20 ° C. and has a linear or branched saturated or unsaturated hydrocarbon group. In the present invention, “liquid at 20 ° C.” is determined as liquid according to the solid-liquid determination standard defined in ASTM standard ASTM D4359-90.
Examples of the higher fatty acid of component (B) include unsaturated fatty acids having 12 to 24 carbon atoms and branched fatty acids, such as oleic acid, palmitoleic acid, linoleic acid, linolenic acid, isostearic acid, and isopalmitic acid. . In addition, branched fatty acids extracted from vegetable oils such as soybean oil and cottonseed oil or hardened oils, branched fatty acids generated as by-products in the production of dimer acids using vegetable oils as raw materials, and the like can also be used.
成分(B)としては、液状オイル組成物の保湿性を向上させる観点から、オレイン酸、リノール酸、リノレン酸、イソステアリン酸、イソパルミチン酸が好ましく、オレイン酸、イソステアリン酸がより好ましい。 As the component (B), oleic acid, linoleic acid, linolenic acid, isostearic acid, and isopalmitic acid are preferable, and oleic acid and isostearic acid are more preferable from the viewpoint of improving the moisture retention of the liquid oil composition.
成分(B)は、1種又は2種以上を組み合わせて用いることができ、その含有量は液状オイル組成物の保湿性を向上させる観点から、全組成中に0.1質量%以上であり、0.2質量%以上が好ましく、0.5質量%以上がより好ましく、10質量%以下であり、8質量%以下が好ましく、5質量%以下がより好ましい。また、成分(B)の含有量は、全組成中に0.1〜10質量%であり、0.2〜8質量%が好ましく、0.5〜5質量%がより好ましい。 Component (B) can be used alone or in combination of two or more thereof, and its content is 0.1% by mass or more in the total composition from the viewpoint of improving the moisture retention of the liquid oil composition, 0.2 mass% or more is preferable, 0.5 mass% or more is more preferable, it is 10 mass% or less, 8 mass% or less is preferable, and 5 mass% or less is more preferable. Moreover, content of a component (B) is 0.1-10 mass% in the whole composition, 0.2-8 mass% is preferable, and 0.5-5 mass% is more preferable.
本発明において、成分(B)に対する成分(A)の質量比(A)/(B)は、液状オイル組成物の保湿性及び皮膚への残留性を向上させる観点から、0.001以上であるのが好ましく、0.005以上がより好ましく、0.008以上がさらに好ましく、0.01以上がよりさらに好ましく、1以下が好ましく、0.8以下がより好ましく、0.6以下がさらに好ましく、0.4以下がよりさらに好ましい。また、成分(B)に対する成分(A)の質量比は、(A)/(B)=0.001〜1が好ましく、0.005〜0.8がより好ましく、0.008〜0.6がさらに好ましく、0.01〜0.4がよりさらに好ましい。 In the present invention, the mass ratio (A) / (B) of the component (A) to the component (B) is 0.001 or more from the viewpoint of improving the moisture retention and the persistence on the skin of the liquid oil composition. Preferably, 0.005 or more is more preferable, 0.008 or more is more preferable, 0.01 or more is more preferable, 1 or less is preferable, 0.8 or less is more preferable, 0.6 or less is further preferable, 0.4 or less is even more preferable. The mass ratio of component (A) to component (B) is preferably (A) / (B) = 0.001 to 1, more preferably 0.005 to 0.8, and 0.008 to 0.6. Is more preferable, and 0.01 to 0.4 is still more preferable.
(C)エステル油及び/又はエーテル油:
成分(C)のうち、エステル油としては、炭素数8〜28の直鎖又は分岐鎖の飽和又は不飽和の脂肪酸と、炭素数2〜28の直鎖又は分岐鎖の飽和又は不飽和のアルコールとのエステル油が好ましく、例えば、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、イソステアリン酸イソプロピル、ステアリン酸ブチル、ジカプリン酸ネオペンチルグリコール、トリ(2−エチルヘキサン酸)グリセリン、トリ(カプリル酸・カプリン酸)グリセリン、トリカプロイン、2−エチルヘキサン酸セチル、2−エチルヘキサン酸ペンタエリスリチル、アジピン酸ジイソブチル、アジピン酸2−ヘキシルデシル、アジピン酸ジ−2−ヘプチルウンデシル、イソステアリン酸イソステアリル、トリイソステアリン酸トリメチロールプロパン、2−エチルヘキサン酸セチル、ジ−2−エチルヘキサン酸ネオペンチルグリコール、トリ−2−エチルヘキサン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタエリスリトール、オクタン酸セチル、オレイン酸オレイル、オレイン酸オクチルドデシル、オレイン酸デシル、コハク酸2−エチルヘキシル、ステアリン酸イソセチル、ステアリン酸ブチル、セバシン酸ジイソプロピル、乳酸セチル、乳酸テトラデシル、パルミチン酸2−エチルヘキシル、パルミチン酸2−ヘキシルデシル、パルミチン酸2−ヘプチルウンデシル、12−ヒドロキシステアリン酸コレステリル、オレイン酸フィトステリル、リンゴ酸ジイソステアリル、パラメトキシケイ皮酸エステル、テトラロジン酸ペンタエリスリット、N−ラウロイル−L−グルタミン酸ジ(フィトステリル・2−オクチルドデシル)、N−ラウロイル−L−グルタミン酸ジ(フィトステリル・ベヘニル・2−オクチルドデシル)等が挙げられ、これらは天然由来であってもよい。
(C) Ester oil and / or ether oil:
Among component (C), as ester oil, it is a C8-28 linear or branched saturated or unsaturated fatty acid and a C2-28 linear or branched saturated or unsaturated alcohol. And ester oils such as isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, myristyl myristate, octyldodecyl myristate, isopropyl palmitate, isopropyl isostearate, butyl stearate, neopentyl glycol dicaprate, tri ( 2-ethylhexanoic acid) glycerin, tri (caprylic acid / capric acid) glycerin, tricaproin, 2-ethylhexanoic acid cetyl, 2-ethylhexanoic acid pentaerythrityl, adipic acid diisobutyl, adipic acid 2-hexyldecyl, adipic acid di − -Heptyl undecyl, isostearyl isostearate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, neopentyl glycol di-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, tetra-2- Pentaerythritol ethylhexanoate, cetyl octanoate, oleyl oleate, octyldodecyl oleate, decyl oleate, 2-ethylhexyl succinate, isocetyl stearate, butyl stearate, diisopropyl sebacate, cetyl lactate, tetradecyl lactate, palmitic acid 2 -Ethylhexyl, 2-hexyldecyl palmitate, 2-heptylundecyl palmitate, cholesteryl 12-hydroxystearate, phytosteryl oleate, diacid malate Sostearyl, paramethoxycinnamate, pentaerythritol tetrarosinate, N-lauroyl-L-glutamate di (phytosteryl 2-octyldodecyl), N-lauroyl-L-glutamate di (phytosteryl behenyl 2-octyldodecyl) Etc., and these may be naturally derived.
これらのうち、液状オイル組成物のなめらか感を向上させる観点から、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、イソステアリン酸イソプロピル、ジカプリン酸ネオペンチルグリコール
が好ましく、イソノナン酸イソノニル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ジカプリン酸ネオペンチルグリコールがより好ましい。
Among these, from the viewpoint of improving the smooth feeling of the liquid oil composition, isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl isostearate, neopentyl glycol dicaprate, isononyl isononanoate, myristine isononanoate Isopropyl acid, isopropyl palmitate, and neopentyl glycol dicaprate are more preferable.
また、成分(C)のうち、エーテル油としては、炭素数8〜28の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基を有するエーテルが好ましく、例えば、アルキル−1,3−ジメチルブチルエーテル、ジカプリリルエーテル、ジカプリルエーテル、ジラウリルエーテル、ジイソステアリルエーテル、ジオクチルエーテル、ノニルフェニルエーテル、ドデシルジメチルブチルエーテル、セチルジメチルブチルエーテル等が挙げられる。
エーテル油としては、液状オイル組成物のなめらか感を向上させる観点から、一般式(2):
R11−O−R12 (2)
(式中、R11 及びR12 は同一又は異なって、炭素数4〜24の直鎖、分岐鎖又は環状のアルキル基を示し、R11 及びR12 の少なくとも1つは2箇所以上で分岐しているアルキル基であり、かつR11 及びR12 の合計炭素数は16〜32である)
で表わされるジアルキルエーテルを含むのがより好ましい。
Among the components (C), the ether oil is preferably an ether having a linear or branched saturated or unsaturated hydrocarbon group having 8 to 28 carbon atoms, such as alkyl-1,3-dimethylbutyl ether. , Dicaprylyl ether, dicapryl ether, dilauryl ether, diisostearyl ether, dioctyl ether, nonylphenyl ether, dodecyl dimethyl butyl ether, cetyl dimethyl butyl ether, and the like.
As the ether oil, from the viewpoint of improving the smooth feeling of the liquid oil composition, the general formula (2):
R 11 —O—R 12 (2)
(In the formula, R 11 and R 12 are the same or different and represent a linear, branched or cyclic alkyl group having 4 to 24 carbon atoms, and at least one of R 11 and R 12 is branched at two or more positions. And the total carbon number of R 11 and R 12 is 16 to 32)
It is more preferable that the dialkyl ether represented by these is included.
式中、R11 及びR12 で示されるもののうち、炭素数4〜24の直鎖アルキル基としては、例えば、ブチル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシル基、ウンデシル基、ドデシル基、トリデシル基、テトラデシル基、ペンタデシル基、ヘキサデシル基、ヘプタデシル基、オクタデシル基、ノナデシル基、エイコシル基、ベヘニル基、ドコシル基、トリコシル基、テトラコシル基等が挙げられ、液状オイル組成物のなめらか感を向上させる観点から、ヘキシル基、オクチル基、デシル基、ヘキサデシル基、オクタデシル基が好ましく、ヘキサデシル基がより好ましい。また、炭素数4〜24の分岐鎖のアルキル基のうち、1箇所で分岐しているものとして、例えば、1−メチルプロピル基、2−メチルプロピル基、t−ブチル基、1,1−ジメチルプロピル基、3−メチルヘキシル基、5−メチルヘキシル基、1−エチルヘキシル基、2−エチルヘキシル基、1−ブチルペンチル基、5−メチルオクチル基、2−ブチルオクチル基、イソトリデシル基、2−ペンチルノニル基、2−ヘキシルデシル基、エメリー型イソステアリル基、2−ヘプチルウンデシル基、2−オクチルドデシル基等が挙げられ、同様の観点から、1,1−ジメチルプロピル基、2−エチルヘキシル基、イソトリデシル基、2−オクチルドデシル基が好ましい。炭素数4〜24の分岐鎖のアルキル基のうち、2箇所以上で分岐しているものとして、例えば、1,3−ジメチルブチル基、1−(1−メチルエチル)−2−メチルプロピル基、1,1,3,3−テトラメチルブチル基、3,5,5−トリメチルヘキシル基、1−(2−メチルプロピル)−3−メチルブチル基、3,7−ジメチルオクチル基、2−(1,3,3−トリメチルブチル)−5,7,7−トリメチルオクチル基等が挙げられ、同様の観点から、1,3−ジメチルブチル基が好ましい。さらに、環状のアルキル基としては、シクロヘキシル基、3−メチルシクロヘキシル基、3,3,5−トリメチルシクロヘキシル基等が挙げられ、同様の観点から、シクロヘキシル基が好ましい。 Among the compounds represented by R 11 and R 12 , examples of the linear alkyl group having 4 to 24 carbon atoms include a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, Undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group, heptadecyl group, octadecyl group, nonadecyl group, eicosyl group, behenyl group, docosyl group, tricosyl group, tetracosyl group, etc., liquid oil composition From the viewpoint of improving smoothness, a hexyl group, an octyl group, a decyl group, a hexadecyl group, and an octadecyl group are preferable, and a hexadecyl group is more preferable. Examples of branched alkyl groups having 4 to 24 carbon atoms that are branched at one position include, for example, 1-methylpropyl group, 2-methylpropyl group, t-butyl group, 1,1-dimethyl group. Propyl group, 3-methylhexyl group, 5-methylhexyl group, 1-ethylhexyl group, 2-ethylhexyl group, 1-butylpentyl group, 5-methyloctyl group, 2-butyloctyl group, isotridecyl group, 2-pentylnonyl Group, 2-hexyldecyl group, emery type isostearyl group, 2-heptylundecyl group, 2-octyldodecyl group and the like. From the same viewpoint, 1,1-dimethylpropyl group, 2-ethylhexyl group, isotridecyl Group and 2-octyldodecyl group are preferred. Examples of branched alkyl groups having 4 to 24 carbon atoms that are branched at 2 or more positions include, for example, 1,3-dimethylbutyl group, 1- (1-methylethyl) -2-methylpropyl group, 1,1,3,3-tetramethylbutyl group, 3,5,5-trimethylhexyl group, 1- (2-methylpropyl) -3-methylbutyl group, 3,7-dimethyloctyl group, 2- (1, 3,3-trimethylbutyl) -5,7,7-trimethyloctyl group and the like, and 1,3-dimethylbutyl group is preferable from the same viewpoint. Furthermore, examples of the cyclic alkyl group include a cyclohexyl group, a 3-methylcyclohexyl group, and a 3,3,5-trimethylcyclohexyl group. From the same viewpoint, a cyclohexyl group is preferable.
成分(C)としては、液状オイル組成物のなめらか感を向上させる観点から、一般式(2)で表されるジアルキルエーテルを含むのが好ましく、アルキル−1,3−ジメチルブチルエーテルがより好ましく、セチル−1,3−ジメチルブチルエーテルがさらに好ましい。 The component (C) preferably includes a dialkyl ether represented by the general formula (2), more preferably alkyl-1,3-dimethylbutyl ether, from the viewpoint of improving the smoothness of the liquid oil composition. More preferred is -1,3-dimethylbutyl ether.
成分(C)は、エステル油及びエーテル油から1種又は2種以上を組み合わせて用いることができ、その含有量は、液状オイル組成物のなめらか感を向上させる観点から、全組成中に0.5質量%以上であり、1質量%以上が好ましく、5質量%以上がより好ましく、50質量%以下であり、40質量%以下が好ましく、30質量%以下がより好ましい。また、成分(C)の含有量は、全組成中に0.5〜50質量%であり、1〜40質量%が好ましく、5〜30質量%がより好ましい。 Component (C) can be used singly or in combination of two or more of ester oil and ether oil, and the content thereof is from 0 to 0.4 in the whole composition from the viewpoint of improving the smooth feeling of the liquid oil composition. 5 mass% or more, preferably 1 mass% or more, more preferably 5 mass% or more, 50 mass% or less, preferably 40 mass% or less, more preferably 30 mass% or less. Moreover, content of a component (C) is 0.5-50 mass% in the whole composition, 1-40 mass% is preferable, and 5-30 mass% is more preferable.
(D)炭化水素油:
成分(D)の炭化水素油は、直鎖又は分岐鎖の炭化水素油のいずれでも良く、例えば、流動パラフィン、軽質イソパラフィン、流動イソパラフィン、イソドデカン、ポリブテン、スクワラン、スクワレン等が挙げられる。
これらのうち、液状オイル組成物のなめらか感を向上させる観点から、流動パラフィン、流動イソパラフィン、イソドデカン、スクワランが好ましく、流動パラフィン、イソドデカン、スクワランがより好ましい。
(D) Hydrocarbon oil:
The hydrocarbon oil of component (D) may be either a linear or branched hydrocarbon oil, and examples thereof include liquid paraffin, light isoparaffin, liquid isoparaffin, isododecane, polybutene, squalane and squalene.
Among these, liquid paraffin, liquid isoparaffin, isododecane, and squalane are preferable, and liquid paraffin, isododecane, and squalane are more preferable from the viewpoint of improving the smooth feeling of the liquid oil composition.
成分(D)は、1種又は2種以上を組み合わせて用いることができ、その含有量は、液状オイル組成物のなめらか感を向上させる観点から、全組成中に8質量%以上であり、10質量%以上が好ましく、15質量%以上がより好ましく、80質量%以下であり、75質量%以下が好ましく、70質量%以下がより好ましい。また、成分(D)の含有量は、全組成中に8〜80質量%であり、10〜75質量%が好ましく、15〜70質量%がより好ましい。 Component (D) can be used alone or in combination of two or more thereof, and the content thereof is 8% by mass or more in the total composition from the viewpoint of improving the smooth feeling of the liquid oil composition. % By mass or more is preferred, 15% by mass or more is more preferred, 80% by mass or less, 75% by mass or less is preferred, and 70% by mass or less is more preferred. Moreover, content of a component (D) is 8-80 mass% in the whole composition, 10-75 mass% is preferable and 15-70 mass% is more preferable.
(E)25℃における粘度が20mPa・s以下のシリコーン油:
成分(E)のシリコーン油は、25℃における粘度が20mPa・s以下のものである。
本発明において、粘度は、B型粘度計TVB−10(ローターNo1,12回転)(東機産業社製)により測定される。
(E) Silicone oil having a viscosity at 25 ° C. of 20 mPa · s or less:
The silicone oil as component (E) has a viscosity at 25 ° C. of 20 mPa · s or less.
In the present invention, the viscosity is measured with a B-type viscometer TVB-10 (rotor No. 1, 12 rotations) (manufactured by Toki Sangyo Co., Ltd.).
成分(E)のシリコーン油としては、例えば、粘度が25℃における粘度が20mPa・s以下である、メチルポリシロキサン、デカメチルテトラシロキサン、オクタメチルトリシロキサン、トリシロキサン等が挙げられる。
これらのうち、液状オイル組成物のなめらか感を向上させる観点から、粘度が25℃における粘度が20mPa・s以下である、メチルポリシロキサン、デカメチルテトラシロキサン、オクタメチルトリシロキサンが好ましく、メチルポリシロキサンがより好ましい。
Examples of the component (E) silicone oil include methylpolysiloxane, decamethyltetrasiloxane, octamethyltrisiloxane, trisiloxane, and the like having a viscosity of 20 mPa · s or less at 25 ° C.
Of these, methylpolysiloxane, decamethyltetrasiloxane, and octamethyltrisiloxane having a viscosity at 25 ° C. of 20 mPa · s or less are preferable from the viewpoint of improving the smoothness of the liquid oil composition, and methylpolysiloxane is preferred. Is more preferable.
成分(E)は、1種又は2種以上を組み合わせて用いることができ、その含有量は、液状オイル組成物のなめらか感及び保湿性を向上させる観点から、全組成中に5質量%以上であり、8質量%以上が好ましく、10質量%以上がより好ましく、15質量%以上がさらにより好ましく、80質量%以下であり、75質量%以下が好ましく、70質量%以下がより好ましく、65質量%以下がさらにより好ましい。また、成分(E)の含有量は、全組成中に5〜80質量%であり、8〜75質量%が好ましく、10〜70質量%がより好ましく、15〜65質量%がさらにより好ましい。 Component (E) can be used alone or in combination of two or more thereof, and the content thereof is 5% by mass or more in the total composition from the viewpoint of improving the smooth feeling and moisture retention of the liquid oil composition. Yes, 8% by mass or more, preferably 10% by mass or more, more preferably 15% by mass or more, 80% by mass or less, 75% by mass or less, more preferably 70% by mass or less, 65% by mass % Or less is even more preferable. Moreover, content of a component (E) is 5-80 mass% in the whole composition, 8-75 mass% is preferable, 10-70 mass% is more preferable, 15-65 mass% is still more preferable.
(F)炭素数12〜24の高級アルコール:
本発明で用いられる成分(F)の高級アルコールは、炭素数12〜24のもので、炭素数14〜22のものが好ましい。
成分(F)としては、例えば、ラウリルアルコール、ミリスチルアルコール、セタノール、ヘキシルデカノール、ステアリルアルコール、イソステアリルアルコール、リノレニルアルコール、オレイルアルコール、アラキジルアルコール、オクチルドデカノール、ベヘニルアルコール、リグノセリルアルコール等が挙げられる。
(F) Higher alcohol having 12 to 24 carbon atoms:
The higher alcohol of component (F) used in the present invention has 12 to 24 carbon atoms, and preferably 14 to 22 carbon atoms.
Examples of the component (F) include lauryl alcohol, myristyl alcohol, cetanol, hexyl decanol, stearyl alcohol, isostearyl alcohol, linolenyl alcohol, oleyl alcohol, arachidyl alcohol, octyldodecanol, behenyl alcohol, lignoceryl alcohol and the like. It is done.
これらのうち、液状オイル組成物の低温安定性及び皮膚への残留性を向上させる観点から、セタノール、ステアリルアルコール、イソステアリルアルコール、オクチルドデカノール、ベヘニルアルコールが好ましく、セタノール、ステアリルアルコール、イソステアリルアルコール、オクチルドデカノールがより好ましい。 Of these, cetanol, stearyl alcohol, isostearyl alcohol, octyldodecanol, and behenyl alcohol are preferred from the viewpoint of improving the low temperature stability of the liquid oil composition and the persistence to the skin, cetanol, stearyl alcohol, isostearyl alcohol, Octyldodecanol is more preferred.
成分(F)は、1種又は2種以上を組み合わせて用いることができ、その含有量は、液状オイル組成物の低温安定性及び皮膚への残留性を向上させる観点から、全組成中に1質量%以上であり、2質量%以上が好ましく、5質量%以上がより好ましく、15質量%以下であり、12質量%以下が好ましく、10質量%以下がより好ましい。また、成分(F)の含有量は、全組成中に1〜15質量%であり、2〜12質量%が好ましく、5〜10質量%がより好ましい。 Component (F) can be used alone or in combination of two or more thereof, and its content is 1 in the total composition from the viewpoint of improving the low temperature stability of the liquid oil composition and its persistence to the skin. % By mass or more, preferably 2% by mass or more, more preferably 5% by mass or more, 15% by mass or less, preferably 12% by mass or less, and more preferably 10% by mass or less. Moreover, content of a component (F) is 1-15 mass% in the whole composition, 2-12 mass% is preferable, and 5-10 mass% is more preferable.
本発明において、成分(D)及び(E)の合計量[(D)+(E)]に対する成分(C)及び(F)の合計量[(C)+(F)]の質量比[(C)+(F)]/[(D)+(E)]は、液状オイル組成物の保湿性と皮膚への残留性を向上させる観点から、0.1以上が好ましく、0.15以上がより好ましく、0.18以上がさらに好ましく、0.19以上がよりさらに好ましく、0.2以上がさらに好ましく、1.5以下が好ましく、1以下がより好ましく、0.7以下がさらに好ましく、0.4以下がよりさらに好ましく、0.3以下がさらに好ましい。また、成分(D)及び(E)の合計量[(D)+(E)]に対する成分(C)及び(F)の合計量[(C)+(F)]の質量比は、[(C)+(F)]/[(D)+(E)]=0.1〜1.5が好ましく、0.15〜1がより好ましく、0.18〜0.7がさらに好ましく、0.19〜0.4がよりさらに好ましく、0.2〜0.3がさらに好ましい。 In the present invention, the mass ratio [(C) + (F)] of the total amount [(C) + (F)] of the components (C) and (F) to the total amount [(D) + (E)] of the components (D) and (E) [( C) + (F)] / [(D) + (E)] is preferably 0.1 or more, more preferably 0.15 or more, from the viewpoint of improving the moisture retention and the persistence to the skin of the liquid oil composition. More preferably, 0.18 or more is more preferable, 0.19 or more is more preferable, 0.2 or more is further preferable, 1.5 or less is preferable, 1 or less is more preferable, 0.7 or less is more preferable, 0 .4 or less is more preferable, and 0.3 or less is more preferable. The mass ratio of the total amount [(C) + (F)] of the components (C) and (F) to the total amount [(D) + (E)] of the components (D) and (E) is [( C) + (F)] / [(D) + (E)] = 0.1 to 1.5 is preferable, 0.15 to 1 is more preferable, 0.18 to 0.7 is further preferable, and 19-0.4 is still more preferable, and 0.2-0.3 is further more preferable.
本発明の液状オイル組成物において、水の含有量は、均一で外観の良好な組成物を得る観点から、全組成中に1質量%以下が好ましく、0.5質量%以下がより好ましく、0.1質量%以下がさらに好ましく、0.05質量%以下がよりさらに好ましく、0.01質量%以下がさらに好ましく、実質0であるのがよりさらに好ましい。
また、本発明の液状オイル組成物は、界面活性剤を含有することができるが、均一で外観の良好な組成物を得る観点から、前記成分以外の界面活性剤の含有量は、全組成中に3質量%以下が好ましく、2質量%以下がより好ましく、1質量%以下がさらに好ましく、0.1質量%以下がよりさらに好ましく、0.01質量%以下がさらに好ましく、実質0であるのがよりさらに好ましい。
In the liquid oil composition of the present invention, the water content is preferably 1% by mass or less, more preferably 0.5% by mass or less, and 0% by mass from the viewpoint of obtaining a uniform and good appearance composition. 0.1% by mass or less is more preferable, 0.05% by mass or less is more preferable, 0.01% by mass or less is further preferable, and substantially 0 is more preferable.
In addition, the liquid oil composition of the present invention can contain a surfactant, but from the viewpoint of obtaining a uniform and good-looking composition, the content of surfactants other than the above components is in the total composition. 3 mass% or less is preferable, 2 mass% or less is more preferable, 1 mass% or less is more preferable, 0.1 mass% or less is further more preferable, 0.01 mass% or less is further more preferable, and it is substantially 0. Is even more preferable.
本発明の液状オイル組成物は、化粧料として好適であり、皮膚化粧料として、更に保湿効果を高める皮膚化粧料としてより好適である。
本発明の液状オイル組成物は、化粧料とする場合、更に通常の化粧料に用いられる成分、例えば、前記以外の油性成分、保湿剤、増粘剤、殺菌剤、湿潤剤、着色剤、防腐剤、感触向上剤、粉体、香料、抗炎症剤、美白剤、制汗剤、前記油性成分以外の紫外線吸収剤、酸化防止剤等を、適宜含有することができる。
The liquid oil composition of the present invention is suitable as a cosmetic, more suitable as a skin cosmetic, and as a skin cosmetic that further enhances the moisturizing effect.
When the liquid oil composition of the present invention is used as a cosmetic, it is further used in components for ordinary cosmetics, for example, other oil components, moisturizers, thickeners, bactericides, wetting agents, colorants, antiseptics. Agents, feel improvers, powders, fragrances, anti-inflammatory agents, whitening agents, antiperspirants, UV absorbers other than the oily components, antioxidants, and the like can be appropriately contained.
本発明の液状オイル組成物は、通常の方法により、配合成分を混合することにより、製造することができる。
本発明の液状オイル組成物は、皮膚化粧料とした場合、皮膚、毛髪、顔、身体、手足等のいずれかに塗布することにより、使用することができる。
また、本発明の液状オイル組成物は、皮膚化粧料とした場合、皮膚、毛髪、顔、身体、手足等のいずれかに塗布し、洗い流さない及び/又は拭き取らない態様で使用することができる。
The liquid oil composition of this invention can be manufactured by mixing a compounding component by a normal method.
When the liquid oil composition of the present invention is used as a skin cosmetic, it can be used by applying it to any of skin, hair, face, body, limbs and the like.
In addition, when the liquid oil composition of the present invention is used as a skin cosmetic, it can be applied to any of the skin, hair, face, body, limbs, etc., and used without being washed off and / or wiped off. .
実施例1〜12、比較例1〜6
表1に示す組成の液状オイル組成物を製造し、低温安定性、水分量、残留性及びなめらか感を評価した。結果を表1に併せて示す。
なお、実施例7〜12は参考例であって、本発明の範囲に含まれるものではない。
Examples 1-12, Comparative Examples 1-6
Liquid oil compositions having the compositions shown in Table 1 were produced and evaluated for low temperature stability, moisture content, persistence and smoothness. The results are also shown in Table 1.
Examples 7 to 12 are reference examples and are not included in the scope of the present invention.
(製造方法)
成分(A)、(B)、(C)及び(F)を混合し、60℃で、10分撹拌し、均一混合する。その後、成分(D)及び(E)を加え、30℃まで、冷却しながら(1℃/min)混合し、液状オイル組成物を得た。
(Production method)
Components (A), (B), (C) and (F) are mixed, stirred at 60 ° C. for 10 minutes, and uniformly mixed. Thereafter, components (D) and (E) were added, and mixed to 30 ° C. while cooling (1 ° C./min) to obtain a liquid oil composition.
(評価方法)
(1)低温安定性:
各液状オイル組成物を、−5℃で1ヶ月保存した後、室温(25℃)に戻したときの状態を、目視により、以下の基準で評価した。
4;目視及び顕微鏡で結晶が見られない。
3;結晶が目視では観察されないが、顕微鏡で確認される。
2;目視で白濁が観察される。
1;目視結晶の析出が観察される。
(Evaluation method)
(1) Low temperature stability:
Each liquid oil composition was stored at −5 ° C. for 1 month, and then the state when it was returned to room temperature (25 ° C.) was visually evaluated according to the following criteria.
4: No crystals are seen visually and with a microscope.
3; Crystals are not observed visually, but are confirmed with a microscope.
2: The cloudiness is observed visually.
1; Visual crystal precipitation is observed.
(2)保湿性(水分量):
前腕内側を石鹸で洗浄し、タオルドライ後10分経過後、洗浄後の前腕内側部の皮膚水分量をコルネオメータ(Courage + Khazaka electronic GmbH)にて測定する。次に、各液状オイル組成物を20μL/cm2塗布し、6時間後、同じ部位をコルネオメータにて測定する。塗布前後でのコルネオ値の変化量を求めた。コルネオ値の変化量が大きいほど、体内から蒸散される水分が液状オイル組成物に保持されている、すなわち保湿性が優れていることを示す。なお、本試験は、20℃、湿度40%の環境下で行なった。
(2) Moisturizing property (water content):
The inside of the forearm is washed with soap, and after 10 minutes have passed since the towel was dried, the moisture content of the skin on the inside of the forearm after washing is measured with a corneometer (Courage + Khazaka electronic GmbH). Next, 20 μL / cm 2 of each liquid oil composition is applied, and after 6 hours, the same part is measured with a corneometer. The amount of change in Corneo value before and after application was determined. It shows that the water | moisture content transpired from a body is hold | maintained by the liquid oil composition, ie, moisture retention is excellent, so that the variation | change_quantity of a Corneo value is large. This test was conducted in an environment of 20 ° C. and humidity of 40%.
(3)残留性:
各液状オイル組成物に油溶性蛍光剤(ナイルレッド)を0.01%となるように加える。これを豚皮(3cm×3cm)に20μL/cm2塗布し、1時間放置(30℃、湿度40%)する。その後、1Lの蒸留水を入れたビーカー内で5分間撹拌洗浄する。タオルドライ後、表面を10mLのエタノールで洗浄し、洗浄液を回収する。回収した溶液を1mLまで濃縮し、高速液体クロマトグラフにより、以下の条件で定量する。
装置:日立F−7000システム
溶離液:アセトニトリル/水=90/10、40℃、1mL/min
検出器:蛍光(Ex:540、 Em:640)
カラム:ODS−2
塗布した組成物のナイルレッド量と、残留評価後に表面に残ったナイルレッド量を定量し、これらの結果より、塗布量に対する残留量の割合を計算して求めた。数値が高いほど皮膚への残留性に優れることを示す。
(3) Persistence:
An oil-soluble fluorescent agent (Nile Red) is added to each liquid oil composition to 0.01%. This is applied to pork skin (3 cm × 3 cm) at 20 μL / cm 2 and allowed to stand for 1 hour (30 ° C., humidity 40%). Then, it is washed by stirring for 5 minutes in a beaker containing 1 L of distilled water. After towel drying, the surface is washed with 10 mL of ethanol, and the washing solution is collected. The collected solution is concentrated to 1 mL and quantified by high performance liquid chromatography under the following conditions.
Apparatus: Hitachi F-7000 system eluent: acetonitrile / water = 90/10, 40 ° C., 1 mL / min
Detector: Fluorescence (Ex: 540, Em: 640)
Column: ODS-2
The amount of Nile Red in the applied composition and the amount of Nile Red remaining on the surface after the residue evaluation were quantified, and from these results, the ratio of the residual amount to the coating amount was calculated and determined. It shows that it is excellent in the persistence to skin, so that a numerical value is high.
(4)なめらか感:
専門パネル5名により、各液状オイル組成物を皮膚(下腕)に塗布したときのなめらか感を、以下の基準で官能評価し、平均値を求めた。
5;とてもなめらか。
4;非常になめらかである。
3;ややなめらかである。
2;なめらか感が足りない。
1;なめらかでない。
(4) Smooth feeling:
The sense of smoothness when each liquid oil composition was applied to the skin (lower arm) was sensory-evaluated by the following criteria by five specialist panels, and the average value was obtained.
5: Very smooth.
4; It is very smooth.
3; Slightly smooth.
2; lack of smoothness.
1; not smooth.
処方例1
以下に示す組成の液状オイル組成物を製造した。
得られた液状オイル組成物は、低温での保存安定性が良好で、肌へのなじみが良く、なめらかで、皮膚への残留性に優れ、しっとり感を与え、保湿効果の持続性に優れたものであった。
Formulation Example 1
A liquid oil composition having the following composition was produced.
The resulting liquid oil composition has good storage stability at low temperatures, is well-familiar with the skin, is smooth, has excellent persistence on the skin, gives a moist feeling, and has a long-lasting moisturizing effect. It was a thing.
(製造方法)
コレステロール、イソステアリン酸コレステリル、セタノール、ステアリルアルコール、イソステアリン酸、イソノナン酸イソノニル、パルミチン酸イソプロピル及びセチル−1,3−ジメチルブチルエーテルを混合し、60℃で、10分撹拌し、均一混合する。その後、残りの成分を加え、30℃まで、冷却しながら(1℃/min)混合し、液状オイル組成物を得た。
(Production method)
Cholesterol, cholesteryl isostearate, cetanol, stearyl alcohol, isostearic acid, isononyl isononanoate, isopropyl palmitate and cetyl-1,3-dimethylbutyl ether are mixed, stirred at 60 ° C. for 10 minutes, and mixed uniformly. Thereafter, the remaining components were added and mixed with cooling to 30 ° C. (1 ° C./min) to obtain a liquid oil composition.
<液状オイル組成物>
コレステロール*1 0.01(質量%)
イソステアリン酸コレステリル*2 0.01
セタノール*3 0.3
ステアリルアルコール*4 0.05
イソステアリン酸*5 1.0
イソノナン酸イソノニル*6 0.5
パルミチン酸イソプロピル*7 20.0
セチル−1,3−ジメチルブチルエーテル*8 0.50
流動パラフィン*9 40.0
メチルポリシロキサン*10 37.52
月見草油 0.01
ラベンダー油 0.01
ホホバ油 0.01
香料 0.08
合計 100.00
*1)海麗マリンコレステロール、日本水産社製
*2)エキセパールIS-CE-A、花王社製
*3)セチルアルコールNX、高級アルコール工業社製
*4)ステアリルアルコールNX、高級アルコール工業社製
*5)イソステアリン酸EX、高級アルコール工業社製
*6)サラコス99、日清オイリオグループ社製
*7)エキセパール IPP、花王社製
*8)ASE166K、花王社製
*9)ハイコールK−350、カネダ社製
*10)シリコーン KF−96L−2CS、信越化学工業社製
<Liquid oil composition>
Cholesterol * 1 0.01 (mass%)
Cholesteryl isostearate * 2 0.01
Cetanol * 3 0.3
Stearyl alcohol * 4 0.05
Isostearic acid * 5 1.0
Isononyl isononanoate * 6 0.5
Isopropyl palmitate * 7 20.0
Cetyl-1,3-dimethylbutyl ether * 8 0.50
Liquid paraffin * 9 40.0
Methylpolysiloxane * 10 37.52
Evening primrose oil 0.01
Lavender oil 0.01
Jojoba oil 0.01
Perfume 0.08
Total 100.00
* 1) Kairei Marine Cholesterol, manufactured by Nihon Suisan * 2) Exepal IS-CE-A, manufactured by Kao * 3) Cetyl alcohol NX, manufactured by Higher Alcohol Industry * 4) Stearyl alcohol NX, manufactured by Higher Alcohol Industrial * 5) Isostearic acid EX, manufactured by Higher Alcohol Industry * 6) Saracos 99, manufactured by Nisshin Oillio Group * 7) Exepal IPP, manufactured by Kao * 8) ASE166K, manufactured by Kao * 9) High Coal K-350, Kaneda * 10) Silicone KF-96L-2CS, manufactured by Shin-Etsu Chemical Co., Ltd.
処方例2
以下に示す組成の液状オイル組成物を製造した。
得られた液状オイル組成物は、低温での保存安定性が良好で、肌へのなじみが良く、なめらかで、皮膚への残留性に優れ、しっとり感を与え、保湿効果の持続性にすぐれたものであった。
Formulation Example 2
A liquid oil composition having the following composition was produced.
The resulting liquid oil composition has good storage stability at low temperatures, is well-familiar with the skin, is smooth, has excellent persistence on the skin, gives a moist feeling, and has a long-lasting moisturizing effect. It was a thing.
(製造方法)
ジカプリン酸ネオペンチルグリコール、オクチルドデカノール、イソステアリン酸コレステリル、セタノール、イソステアリン酸、パルミチン酸イソプロピル、セチル−1,3−ジメチルブチルエーテル、イソドデカン、スクワラン及びl−メントールを混合し、60℃で、10分撹拌し、均一混合する。その後、残りの成分を加え、30℃まで、冷却しながら(1℃/min)混合し、液状オイル組成物を得た。
(Production method)
Mix neopentyl glycol dicaprate, octyldodecanol, cholesteryl isostearate, cetanol, isostearic acid, isopropyl palmitate, cetyl-1,3-dimethylbutyl ether, isododecane, squalane and l-menthol, and stir at 60 ° C. for 10 minutes. And mix evenly. Thereafter, the remaining components were added and mixed with cooling to 30 ° C. (1 ° C./min) to obtain a liquid oil composition.
<液状オイル組成物>
ジカプリン酸ネオペンチルグリコール*11 1.0(質量%)
オクチルドデカノール*12 6.0
イソステアリン酸コレステリル*2 0.1
セタノール*3 0.3
イソステアリン酸*5 1.0
パルミチン酸イソプロピル*7 5.0
セチル−1,3−ジメチルブチルエーテル*8 0.5
イソドデカン*13 20.0
スクワラン*14 15.5
l−メントール 0.1
メチルポリシロキサン*15 43.5
エタノール 2.0
パラメトキシケイ皮酸−エチルヘキシル 5.0
合計 100.0
*11)エステモールN−01、日清オイリオグループ社製
*12)カルコール200GD、花王社製
*13)マルカゾールR、丸善石油社製
*14)ニッコールスクワラン、日光ケミカルズ社製
*15)シリコーン KF−96A−10CS、信越化学工業社製
<Liquid oil composition>
Neopentyl glycol dicaprate * 11 1.0 (mass%)
Octyldodecanol * 12 6.0
Cholesteryl isostearate * 2 0.1
Cetanol * 3 0.3
Isostearic acid * 5 1.0
Isopropyl palmitate * 7 5.0
Cetyl-1,3-dimethylbutyl ether * 8 0.5
Isododecane * 13 20.0
Squalane * 14 15.5
l-Menthol 0.1
Methyl polysiloxane * 15 43.5
Ethanol 2.0
Paramethoxycinnamic acid-ethylhexyl 5.0
Total 100.0
* 11) Estemol N-01, Nisshin Oillio Group * 12) Calcoal 200GD, Kao * 13) Marcazole R, Maruzen Petroleum * 14) Nikkor Squalane, Nikko Chemicals * 15) Silicone KF- 96A-10CS, manufactured by Shin-Etsu Chemical Co., Ltd.
Claims (3)
(A)ステロール類 0.01〜1質量%、
(B)20℃で液状の炭素数12〜24の高級脂肪酸 0.1〜10質量%、
(C)エステル油及び/又はエーテル油 0.5〜50質量%、
(D)炭化水素油 8〜80質量%、
(E)25℃における粘度が20mPa・s以下のシリコーン油 5〜80質量%、
(F)炭素数12〜24の高級アルコール 1〜15質量%
を含有し、
成分(D)及び(E)の合計量[(D)+(E)]に対する成分(C)及び(F)の合計量[(C)+(F)]の質量比が、[(C)+(F)]/[(D)+(E)]=0.18〜0.4であり、
成分(B)に対する成分(A)の質量比が、(A)/(B)=0.008〜0.10である液状オイル組成物。 The following components (A), (B), (C), (D), (E) and (F):
(A) Sterols 0.01-1% by mass,
(B) 0.1 to 10% by mass of a higher fatty acid having 12 to 24 carbon atoms which is liquid at 20 ° C.
(C) Ester oil and / or ether oil 0.5-50 mass%,
(D) 8 to 80% by mass of hydrocarbon oil,
(E) 5 to 80% by mass of a silicone oil having a viscosity at 25 ° C. of 20 mPa · s or less,
(F) 1 to 15% by mass of a higher alcohol having 12 to 24 carbon atoms
Containing
The mass ratio of the total amount [(C) + (F)] of the components (C) and (F) to the total amount [(D) + (E)] of the components (D) and (E) is [(C) + (F)] / [(D) + (E)] = 0.18 to 0.4 ,
Weight ratio of component (A) to component (B) is, (A) / (B) = 0.008 ~ liquid oil composition is 0.10.
R11−O−R12 (1)
(式中、R11 及びR12 は同一又は異なって、炭素数4〜24の直鎖、分岐鎖又は環状のアルキル基を示し、R11 及びR12 の少なくとも1つは2箇所以上で分岐しているアルキル基であり、かつR11 及びR12 の合計炭素数は16〜32である)
で表わされるジアルキルエーテルを含む請求項1記載の液状オイル組成物。 Component (C) is represented by the general formula (1):
R 11 —O—R 12 (1)
(In the formula, R 11 and R 12 are the same or different and represent a linear, branched or cyclic alkyl group having 4 to 24 carbon atoms, and at least one of R 11 and R 12 is branched at two or more positions. And the total carbon number of R 11 and R 12 is 16 to 32)
The liquid oil composition of Claim 1 containing the dialkyl ether represented by these.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014113203A JP6487635B2 (en) | 2014-05-30 | 2014-05-30 | Liquid oil composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014113203A JP6487635B2 (en) | 2014-05-30 | 2014-05-30 | Liquid oil composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015227301A JP2015227301A (en) | 2015-12-17 |
JP6487635B2 true JP6487635B2 (en) | 2019-03-20 |
Family
ID=54885027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014113203A Active JP6487635B2 (en) | 2014-05-30 | 2014-05-30 | Liquid oil composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6487635B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6960743B2 (en) * | 2016-02-29 | 2021-11-05 | 日本精化株式会社 | Small molecule silicone alternative oil |
JP7599285B2 (en) | 2020-06-10 | 2024-12-13 | 株式会社 資生堂 | Oil-in-oil cosmetics |
JP7403828B2 (en) * | 2020-08-05 | 2023-12-25 | 株式会社みらい中央研究所 | Oily particle composition for cosmetics |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3453462B2 (en) * | 1995-09-05 | 2003-10-06 | 花王株式会社 | Cosmetics |
JP2006096703A (en) * | 2004-09-29 | 2006-04-13 | Croda Japan Kk | Sterol derivative |
JP2014047137A (en) * | 2012-08-29 | 2014-03-17 | Hifu Rinsho Yakuri Kenkyusho Kk | Massage oil composition |
-
2014
- 2014-05-30 JP JP2014113203A patent/JP6487635B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015227301A (en) | 2015-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7829106B2 (en) | Cosmetic composition and cosmetic | |
JP2022087249A (en) | Oil-in-water emulsion composition | |
JP6267022B2 (en) | Makeup cosmetics | |
JP2013542989A (en) | Moisturizing composition for lips | |
JP5395329B2 (en) | Gel composition | |
JP5399701B2 (en) | Whitening skin external preparation and skin whitening method | |
US10850136B2 (en) | Moisturiser blend | |
JP6487635B2 (en) | Liquid oil composition | |
JP6486613B2 (en) | Liquid oil composition | |
JP2007246453A (en) | Solid cosmetic | |
JP6012426B2 (en) | Oily liquid cleansing cosmetic | |
JP4817435B2 (en) | Topical skin preparation | |
JP5973256B2 (en) | Skin care method and cosmetics used therefor | |
JP6644606B2 (en) | Liquid oily cosmetic | |
JP5777859B2 (en) | Emulsified composition | |
JP6487634B2 (en) | Liquid oil composition | |
JP6662606B2 (en) | Skin cosmetic composition | |
JP2024506121A (en) | water-based emulsion | |
JP6081097B2 (en) | Oil-in-water emulsion composition | |
JP5495852B2 (en) | Topical skin preparation | |
JP5545701B2 (en) | Aqueous gel cosmetics | |
JP5999903B2 (en) | Liquid cosmetics | |
JP5389412B2 (en) | Skin emulsified composition | |
TW201210625A (en) | External preparation for skin | |
JPH09175936A (en) | Cleansing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170308 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180328 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180807 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190205 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190222 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6487635 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |